$RVRF
River Financial Corp

2017 Q1 Form 10-Q Financial Statement

#000156459017010830 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $7.836M $7.217M
YoY Change 8.58% 83.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $217.0K $201.0K
YoY Change 7.96% 59.52%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $585.0K $595.0K
YoY Change -1.68% 95.08%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.302M $2.474M
YoY Change 33.47% 81.25%
Income Tax $1.073M $751.0K
% Of Pretax Income 32.5% 30.36%
Net Earnings $2.229M $1.723M
YoY Change 29.37% 79.67%
Net Earnings / Revenue 28.45% 23.87%
Basic Earnings Per Share $0.44 $0.35
Diluted Earnings Per Share $0.43 $0.35
COMMON SHARES
Basic Shares Outstanding 5.085M 4.866M
Diluted Shares Outstanding 5.142M 4.991M

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $11.26M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $724.8M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $15.99M
YoY Change
Common Stock $69.70M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $97.00K
YoY Change
Treasury Stock Shares $5.240K
Shareholders Equity $83.40M $79.26M
YoY Change
Total Liabilities & Shareholders Equity $808.8M $725.6M
YoY Change 11.46%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $2.229M $1.723M
YoY Change 29.37% 79.67%
Depreciation, Depletion And Amortization $217.0K $201.0K
YoY Change 7.96% 59.52%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $579.0K $544.0K
YoY Change 6.43% -25.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $1.272M $812.0K
YoY Change 56.65% 93.79%
Common Stock Issuance & Retirement, Net $29.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures $579.0K $544.0K
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
702000
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
RIVER FINANCIAL CORPORATION
CY2017Q1 us-gaap Notes Payable
NotesPayable
6161000
CY2017Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
3409000
CY2017Q1 us-gaap Liabilities
Liabilities
724778000
CY2017Q1 ck0001641601 Temporary Equity Value Including Additional Paid In Capital
TemporaryEquityValueIncludingAdditionalPaidInCapital
612000
CY2016Q4 ck0001641601 Temporary Equity Value Including Additional Paid In Capital
TemporaryEquityValueIncludingAdditionalPaidInCapital
623000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
5091000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64611000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15989000
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001641601
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5089850
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10044
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5090901
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5085661
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5240
CY2016Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
413000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2016Q4 us-gaap Notes Payable
NotesPayable
6428000
CY2016Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
3592000
CY2016Q4 us-gaap Liabilities
Liabilities
727967000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
5091000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64656000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15032000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2153000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
81827000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
176000
CY2017Q1 ck0001641601 Stockholders Equity Before Reclassifications
StockholdersEquityBeforeReclassifications
84014000
CY2017Q1 ck0001641601 Common Stock Related To Employee Stock Ownership Plan
CommonStockRelatedToEmployeeStockOwnershipPlan
612000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
83402000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
808792000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5090901
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5080857
CY2017Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6785000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2016Q4 ck0001641601 Common Stock Related To Employee Stock Ownership Plan
CommonStockRelatedToEmployeeStockOwnershipPlan
623000
CY2016Q4 ck0001641601 Stockholders Equity Before Reclassifications
StockholdersEquityBeforeReclassifications
82450000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
810417000
CY2016Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6479000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
573000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2802000
CY2017Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
63000
CY2017Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7836000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
908000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
536000
CY2016Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
4398000
CY2017Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
5943000
CY2017Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
286000
CY2016Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
271000
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000
CY2017Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
92000
CY2016Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
106000
CY2017Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
11000
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6250
CY2017Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1446
CY2017Q1 ck0001641601 Provision For Losses On Foreclosed Assets
ProvisionForLossesOnForeclosedAssets
30000
CY2017Q1 ck0001641601 Legal And Other Professional Services
LegalAndOtherProfessionalServices
126000
CY2016Q1 ck0001641601 Legal And Other Professional Services
LegalAndOtherProfessionalServices
214000
CY2017Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
798000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1580000
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
97000
CY2016Q1 ck0001641601 Provision For Losses On Foreclosed Assets
ProvisionForLossesOnForeclosedAssets
45000
CY2017Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
544000
CY2016Q1 us-gaap Interest Income Federal Funds Sold And Securities Purchased Under Agreements To Resell
InterestIncomeFederalFundsSoldAndSecuritiesPurchasedUnderAgreementsToResell
7000
CY2016Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
400000
CY2017Q1 ck0001641601 Accretion Of Discount On Securities Available For Sale
AccretionOfDiscountOnSecuritiesAvailableForSale
8000
CY2016Q1 ck0001641601 Accretion Of Discount On Securities Available For Sale
AccretionOfDiscountOnSecuritiesAvailableForSale
8000
CY2016Q1 ck0001641601 Accretion Of Discount On Acquired Loans
AccretionOfDiscountOnAcquiredLoans
455000
CY2016Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
98000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
169000
CY2017Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
519000
CY2016Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-97000
CY2017Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
5000
CY2016Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
4000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-13000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
49000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-182000
CY2016Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
19000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
201000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-792000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5643000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
2229000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1723000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2017Q1 ck0001641601 Interest Expense Note Payable
InterestExpenseNotePayable
61000
CY2017Q1 us-gaap Interest Expense
InterestExpense
585000
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7251000
CY2017Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
360000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2017Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6891000
CY2017Q1 us-gaap Fees And Commissions Depositor Accounts
FeesAndCommissionsDepositorAccounts
699000
CY2017Q1 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
25000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2017Q1 ck0001641601 Mortgage Banking Income
MortgageBankingIncome
409000
CY2016Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2017Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
104000
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
335000
CY2017Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
70000
CY2016Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
68000
CY2017Q1 us-gaap Noninterest Income
NoninterestIncome
1307000
CY2016Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
198000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
338000
CY2016Q1 us-gaap Noninterest Income
NoninterestIncome
1012000
CY2017Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2717000
CY2016Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2548000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2061000
CY2017Q1 us-gaap Occupancy Net
OccupancyNet
330000
CY2016Q1 us-gaap Occupancy Net
OccupancyNet
351000
CY2017Q1 us-gaap Equipment Expense
EquipmentExpense
183000
CY2016Q1 us-gaap Equipment Expense
EquipmentExpense
240000
CY2017Q1 us-gaap Communication
Communication
55000
CY2016Q1 us-gaap Communication
Communication
63000
CY2017Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
115000
CY2016Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
112000
CY2017Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
442000
CY2016Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
480000
CY2017Q1 ck0001641601 Foreclosed Real Estate Expense Benefit
ForeclosedRealEstateExpenseBenefit
38000
CY2016Q1 ck0001641601 Foreclosed Real Estate Expense Benefit
ForeclosedRealEstateExpenseBenefit
50000
CY2017Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000
CY2017Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
29000
CY2017Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1272000
CY2016Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
764000
CY2017Q1 us-gaap Noninterest Expense
NoninterestExpense
4896000
CY2016Q1 us-gaap Noninterest Expense
NoninterestExpense
4928000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3302000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2474000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1073000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
751000
CY2017Q1 ck0001641601 Loss Gain On Sale Of Foreclosed Assets
LossGainOnSaleOfForeclosedAssets
16000
CY2016Q1 ck0001641601 Loss Gain On Sale Of Foreclosed Assets
LossGainOnSaleOfForeclosedAssets
1000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
177000
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
334000
CY2017Q1 us-gaap Increase Decrease In Loans Held For Sale
IncreaseDecreaseInLoansHeldForSale
-3059000
CY2016Q1 us-gaap Increase Decrease In Loans Held For Sale
IncreaseDecreaseInLoansHeldForSale
102000
CY2017Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-45000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1603000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4709000
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3205000
CY2016Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
103000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
579000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
544000
CY2017Q1 ck0001641601 Payments For Proceeds From Restricted Equity Securities Net
PaymentsForProceedsFromRestrictedEquitySecuritiesNet
83000
CY2016Q1 ck0001641601 Payments For Proceeds From Restricted Equity Securities Net
PaymentsForProceedsFromRestrictedEquitySecuritiesNet
-61000
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
33665000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-24756000
CY2017Q1 ck0001641601 Payments For Proceeds From Loan Principal Originations
PaymentsForProceedsFromLoanPrincipalOriginations
-4493000
CY2016Q1 ck0001641601 Payments For Proceeds From Loan Principal Originations
PaymentsForProceedsFromLoanPrincipalOriginations
3322000
CY2017Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
369000
CY2017Q1 ck0001641601 Interest Paid To Depositors
InterestPaidToDepositors
586000
CY2017Q1 ck0001641601 Interest Paid On Borrowings
InterestPaidOnBorrowings
66000
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
425000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-497000
CY2017Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-2975000
CY2016Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
2742000
CY2017Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
236000
CY2016Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
1092000
CY2016Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
7274000
CY2016Q1 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
6750000
CY2016Q1 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
6500000
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7500000
CY2017Q1 ck0001641601 Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
50000
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29000
CY2017Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1272000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-4258000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23371000
CY2015Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
31002000
CY2016Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
5393000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
35513000
CY2017Q1 ck0001641601 Available For Sale Securities Before Residential Mortgage Backed Securities
AvailableForSaleSecuritiesBeforeResidentialMortgageBackedSecurities
78315000
CY2016Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
36000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5084621
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4866049
CY2017Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
514983000
CY2016Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
522055000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
57352
CY2017Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
507891000
CY2017Q1 ck0001641601 Loans And Leases Receivable Net Deferred Loan Fees And Discounts
LoansAndLeasesReceivableNetDeferredLoanFeesAndDiscounts
4888000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69467
CY2016Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
55361
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5141973
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1724000
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2347000
CY2016Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
5393000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
5413000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4990877
CY2017Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
215195000
CY2016Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
485244000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
23383000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
14136000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
35357000
CY2017Q1 ck0001641601 Available For Sale Debt Securities Amortized Cost Basis Before Residential Mortgage Backed Securities
AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeResidentialMortgageBackedSecurities
78289000
CY2016Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
490637000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5408000
CY2017Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
5810000
CY2017Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
1621000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
852000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
23360000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
14034000
CY2017Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
4189000
CY2017Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1127000
CY2016Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7531000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3356000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
186773000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
673000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4085000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
152798000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
145147000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3205000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4011000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
8490000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1376000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
74000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
161288000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
146523000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
3356000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
4085000
CY2017Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2016Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017Q1 ck0001641601 Number Of Securities
NumberOfSecurities
174
CY2017Q1 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Federal Home Loan Bank
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForFederalHomeLoanBank
28919000
CY2016Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Federal Home Loan Bank
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForFederalHomeLoanBank
29873000
CY2017Q1 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Repurchase Agreements
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForRepurchaseAgreements
25107000
CY2016Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Repurchase Agreements
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForRepurchaseAgreements
18392000
CY2017Q1 ck0001641601 Number Of Securities Sold
NumberOfSecuritiesSold
0
CY2016Q1 ck0001641601 Number Of Securities Sold
NumberOfSecuritiesSold
0
CY2016Q4 ck0001641601 Loans And Leases Receivable Net Deferred Loan Fees And Discounts
LoansAndLeasesReceivableNetDeferredLoanFeesAndDiscounts
5614000
CY2017Q1 ck0001641601 Percentage Of Loans And Leases Receivable Gross Carrying Amount
PercentageOfLoansAndLeasesReceivableGrossCarryingAmount
1.018
CY2016Q4 ck0001641601 Percentage Of Loans And Leases Receivable Gross Carrying Amount
PercentageOfLoansAndLeasesReceivableGrossCarryingAmount
1.019
CY2017Q1 ck0001641601 Loans And Leases Receivable Allowance Percentage
LoansAndLeasesReceivableAllowancePercentage
0.008
CY2016Q4 ck0001641601 Loans And Leases Receivable Allowance Percentage
LoansAndLeasesReceivableAllowancePercentage
0.008
CY2017Q1 ck0001641601 Loans And Leases Receivable Net Deferred Loan Fees And Discounts Percentage
LoansAndLeasesReceivableNetDeferredLoanFeesAndDiscountsPercentage
0.010
CY2016Q4 ck0001641601 Loans And Leases Receivable Net Deferred Loan Fees And Discounts Percentage
LoansAndLeasesReceivableNetDeferredLoanFeesAndDiscountsPercentage
0.011
CY2017Q1 ck0001641601 Percentage Of Loans And Leases Receivable Net Reported Amount
PercentageOfLoansAndLeasesReceivableNetReportedAmount
1.000
CY2016Q4 ck0001641601 Percentage Of Loans And Leases Receivable Net Reported Amount
PercentageOfLoansAndLeasesReceivableNetReportedAmount
1.000
CY2017Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
334000
CY2017Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
27000
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1127000
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2933000
CY2016Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
3133000
CY2016Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1275000
CY2016Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
24000
CY2016Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
36000
CY2016Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4071000
CY2017Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
50000
CY2016Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
5686000
CY2017Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2910000
CY2016Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
513344000
CY2016Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4386000
CY2017Q1 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
6258000
CY2016Q4 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
4275000

Files In Submission

Name View Source Status
0001564590-17-010830-index-headers.html Edgar Link pending
0001564590-17-010830-index.html Edgar Link pending
0001564590-17-010830.txt Edgar Link pending
0001564590-17-010830-xbrl.zip Edgar Link pending
ck0001641601-10q_20170331.htm Edgar Link pending
ck0001641601-20170331.xml Edgar Link completed
ck0001641601-20170331.xsd Edgar Link pending
ck0001641601-20170331_cal.xml Edgar Link unprocessable
ck0001641601-20170331_def.xml Edgar Link unprocessable
ck0001641601-20170331_lab.xml Edgar Link unprocessable
ck0001641601-20170331_pre.xml Edgar Link unprocessable
ck0001641601-ex311_8.htm Edgar Link pending
ck0001641601-ex312_7.htm Edgar Link pending
ck0001641601-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending